Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MDAI
MDAI logo

MDAI Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Spectral AI Inc (MDAI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.910
1 Day change
-4.02%
52 Week Range
3.210
Analysis Updated At
2026/04/10
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Spectral AI Inc (MDAI) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has some positive developments, such as showcasing its DeepView® System and appointing a new CFO to strengthen financial leadership, the financial performance is weak, with significant declines in revenue, net income, and EPS. Additionally, technical indicators do not suggest a strong entry point, and there are no significant trading trends or proprietary trading signals to support a buy decision.

Technical Analysis

The MACD is positive and expanding, indicating bullish momentum. However, the RSI is in the neutral zone at 69.209, and moving averages are converging, which does not provide a clear signal. The stock is trading near its resistance level (R1: 1.694), suggesting limited upside potential in the short term.

Positive Catalysts

  • Spectral AI will showcase its DeepView® System at a major industry event, potentially increasing its influence in the burn care sector.

  • Appointment of a new CFO with extensive financial management experience, which could strengthen the company's financial leadership.

Neutral/Negative Catalysts

  • Weak financial performance in Q4 2025, with significant declines in revenue (-46.27% YoY), net income (-113.59% YoY), and EPS (-107.69% YoY).

  • No significant trading trends from hedge funds or insiders, indicating a lack of strong institutional or insider confidence.

Financial Performance

In Q4 2025, the company reported a significant decline in revenue (-46.27% YoY), net income (-113.59% YoY), and EPS (-107.69% YoY). Gross margin improved slightly to 45.18% (+2.61% YoY), but overall financial performance was weak.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target changes provided.

Wall Street analysts forecast MDAI stock price to rise
2 Analyst Rating
Wall Street analysts forecast MDAI stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.990
sliders
Low
3
Averages
4.5
High
6
Current: 1.990
sliders
Low
3
Averages
4.5
High
6
BTIG
Buy
downgrade
$3 -> $2
AI Analysis
2025-05-14
Reason
BTIG
Price Target
$3 -> $2
AI Analysis
2025-05-14
downgrade
Buy
Reason
BTIG lowered the firm's price target on Spectral AI to $2 from $3 and keeps a Buy rating on the shares after its Q1 results. The company is appropriately trimming operating spend to preserve cash, though the firm is reducing its price target to reflect a higher share count, the analyst tells investors in a research note. Spectral AI also continues to expect to submit DeepView to the FDA by the end of 2Q25 with approval expected in early FY26, the firm adds.

People Also Watch